E

Europejskie Centrum Zdrowia Otwock | Onkologia

Research site

(Unclaimed)

Location

Borowa 14/18, Otwock, Mazovia, Poland

Site insights

Top conditions

Top treatments

Cisplatin

Pembrolizumab

Letrozole

L-DOS47

MK-3475-905

PD-0332991

Platinum

BGB-43395

Enfortumab

Vinorelbine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) (SOTERIA)

Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood t...

Active, not recruiting

Pulmonary Arterial Hypertension

Biological: Sotatercept

Locations recently updated

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease (KANDELA-302)

The purpose of this study is to investigate the efficacy and safety of BGB-43395 in combination with letrozole compared with investigator's choice of...

Enrolling

HR+/HER2- Breast Cancer

Drug: Palbociclib

Drug: Letrozole

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

This is a study of perioperative pembrolizumab or enfortumab vedotin in combination with pembrolizumab in participants who are cisplatin-ineligible o...

Active, not recruiting

Urinary Bladder Cancer, Muscle-invasive

Procedure: Surgery (radical cystectomy (RC) plus Pelvic Lymph Node Dissection [PLND])

Drug: Pembrolizumab